Literature DB >> 15313573

Genetic analysis of RGS protein function in Caenorhabditis elegans.

Daniel L Chase1, Michael R Koelle.   

Abstract

Caenorhabditis elegans has close homologs or orthologs of most mammalian (RGS) and G proteins, and mutants for all the RGS and G-protein genes of C. elegans have been generated. C. elegans RGS proteins can be matched to the specific Galpha proteins they regulate in vivo by comparing the defects in animals lacking or transgenically overexpressing an RGS protein with defects in a specific Galpha mutant. Transgenic expression of mutated RGS proteins or subdomains in C. elegans has also been used to carry out structure/function studies of RGS proteins. We propose that similar strategies can be used to understand the function of RGS proteins from other organisms by expressing them in C. elegans. This article describes general considerations regarding such experiments and provides detailed protocols for quantitatively measuring G-protein signaling phenotypes in C. elegans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313573     DOI: 10.1016/S0076-6879(04)89018-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  19 in total

1.  AGS-3 alters Caenorhabditis elegans behavior after food deprivation via RIC-8 activation of the neural G protein G αo.

Authors:  Catherine Hofler; Michael R Koelle
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

2.  Two types of chloride transporters are required for GABA(A) receptor-mediated inhibition in C. elegans.

Authors:  Andrew Bellemer; Taku Hirata; Michael F Romero; Michael R Koelle
Journal:  EMBO J       Date:  2011-03-22       Impact factor: 11.598

3.  A specific subset of transient receptor potential vanilloid-type channel subunits in Caenorhabditis elegans endocrine cells function as mixed heteromers to promote neurotransmitter release.

Authors:  Antony M Jose; I Amy Bany; Daniel L Chase; Michael R Koelle
Journal:  Genetics       Date:  2006-10-22       Impact factor: 4.562

4.  BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Atbin Doroodchi; Hong Xing; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Tracy L Johnson; Stefan Clemens; Fumiaki Yokoi; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Brain Struct Funct       Date:  2020-05-28       Impact factor: 3.270

5.  Regulation of serotonin biosynthesis by the G proteins Galphao and Galphaq controls serotonin signaling in Caenorhabditis elegans.

Authors:  Jessica E Tanis; James J Moresco; Robert A Lindquist; Michael R Koelle
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

6.  Measuring the effects of bacteria on C. elegans behavior using an egg retention assay.

Authors:  Mona Gardner; Mary Rosell; Edith M Myers
Journal:  J Vis Exp       Date:  2013-10-22       Impact factor: 1.355

7.  Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Yuning Liu; Pallavi Girdhar; Keer Zhang; Fumiaki Yokoi; Rui Xiao; Yuqing Li
Journal:  J Neurochem       Date:  2020-09-23       Impact factor: 5.372

8.  The potassium chloride cotransporter KCC-2 coordinates development of inhibitory neurotransmission and synapse structure in Caenorhabditis elegans.

Authors:  Jessica E Tanis; Andrew Bellemer; James J Moresco; Biff Forbush; Michael R Koelle
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

9.  Postsynaptic ERG potassium channels limit muscle excitability to allow distinct egg-laying behavior states in Caenorhabditis elegans.

Authors:  Kevin M Collins; Michael R Koelle
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

10.  RSBP-1 is a membrane-targeting subunit required by the Galpha(q)-specific but not the Galpha(o)-specific R7 regulator of G protein signaling in Caenorhabditis elegans.

Authors:  Morwenna Y Porter; Michael R Koelle
Journal:  Mol Biol Cell       Date:  2009-11-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.